相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Afsaneh Shirani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Increasing age at disability milestones among MS patients in the MSBase Registry
Ilya Kister et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009)
Afsaneh Shirani et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique
Devon S. Conway et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium
Ilya Kister et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Natural History of Multiple Sclerosis: Long-Term Prognostic Factors
Christel Renoux
NEUROLOGIC CLINICS (2011)
Establishing Long-Term Efficacy in Chronic Disease: Use of Recursive Partitioning and Propensity Score Adjustment to Estimate Outcome in MS
Douglas S. Goodin et al.
PLOS ONE (2011)
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray et al.
BRAIN (2010)
Prognostic Factors of Multiple Sclerosis in Lebanon
Bassem Yamout et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
P. J. Veugelers et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Selection bias in observational studies Out of control?
Christopher A. Beck
NEUROLOGY (2009)
Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis - Reply
Maria Trojano et al.
ANNALS OF NEUROLOGY (2008)
Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis
Olivier Gout
ANNALS OF NEUROLOGY (2008)
Immortal time bias in the study of effectiveness of interferon-β in multiple sclerosis
Christel Renoux et al.
ANNALS OF NEUROLOGY (2008)
Comorbidity, socioeconomic status and multiple sclerosis
R. A. Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis
M. Daumer et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2007)
New natural history of interferon-β treated relapsing multiple sclerosis
Maria Trojano et al.
ANNALS OF NEUROLOGY (2007)
Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis - A systematic review
Annette Langer-Gould et al.
ARCHIVES OF NEUROLOGY (2006)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
Estimating long-term effects of disease-modifying drug, therapy in multiple sclerosis patients
RA Rudick et al.
MULTIPLE SCLEROSIS (2005)
The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era
HF McFarland et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Changes in the ascertainment of multiple sclerosis
RA Marrie et al.
NEUROLOGY (2005)
Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization
BMJ Uitdehaag et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
SJ Pittock et al.
NEUROLOGY (2004)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Short-term prognosis in early relapsing-remitting multiple sclerosis
TF Scott et al.
NEUROLOGY (2000)
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years
KP Johnson et al.
MULTIPLE SCLEROSIS JOURNAL (2000)
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts
C Liu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
分享论文
